Incyte Corporation - Common Stock (NQ:INCY)

116.60 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Incyte Corporation - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

30 31 Next >

Where Incyte Stands With Analysts ↗

June 03, 2025

Via Benzinga

Incyte Announces Multiple Presentations, Including New Late-Breaking Data for its mutCALR-Directed Monoclonal Antibody (INCA033989), Accepted for Presentation at EHA 2025

June 03, 2025

From Incyte

Via Business Wire

INCYTE CORP (NASDAQ:INCY) – A Potential Undervalued Opportunity in Biotech ↗

May 30, 2025

INCYTE CORP (NASDAQ:INCY) presents a compelling value case with strong profitability, low debt, and an attractive valuation. The biotech firm's fundamentals suggest potential upside for long-term...

Via Chartmill

Incyte to Present at Upcoming Investor Conference

May 27, 2025

From Incyte

Via Business Wire

What's going on in today's session: S&P500 movers ↗

May 20, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Earnings Scheduled For April 29, 2025 ↗

April 29, 2025

Via Benzinga

3 Mid-Cap Stocks with Questionable Fundamentals

May 20, 2025

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract...

Via StockStory

Incyte Announces FDA Approval of Zynyz® (retifanlimab-dlwr) Making it the First and Only Approved First-Line Treatment for Advanced Anal Cancer Patients in the United States

May 15, 2025

From Incyte

Via Business Wire

INCY Q1 Earnings Call: New Product Launches and Pipeline Progress Drive Outperformance

May 13, 2025

Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 19.5% year on year to $1.05 billion. Its non-GAAP profit...

Via StockStory

Topics World Trade

These S&P500 stocks that are showing activity before the opening bell on Thursday. ↗

May 08, 2025

Curious about the S&P500 stocks that are showing activity before the opening bell on Thursday?

Via Chartmill

INCYTE CORP (NASDAQ:INCY), an undervalued stock with good fundamentals. ↗

May 08, 2025

INCYTE CORP may be an undervalued stock option. NASDAQ:INCY retains a strong financial foundation and an attractive price tag.

Via Chartmill

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 07, 2025

From Incyte

Via Business Wire

Incyte to Present at Upcoming Investor Conference

May 01, 2025

From Incyte

Via Business Wire

INCYTE CORP (NASDAQ:INCY) – A Look at Its Dividend Potential ↗

May 01, 2025

INCYTE CORP (NASDAQ:INCY) – A Look at Its Dividend Potential

Via Chartmill

9 Analysts Have This To Say About Incyte ↗

April 30, 2025

Via Benzinga

Discover the top S&P500 movers in Tuesday's after-hours session. ↗

April 29, 2025

The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top S&P500 gainers and losers driving the post-market movements.

Via Chartmill

Tuesday's pre-market session: top gainers and losers in the S&P500 index ↗

April 29, 2025

Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.

Via Chartmill

Stocks Surge And Bond Yields Fall For 6th Day, Oil Prices Drop To $60: What's Driving Markets Tuesday? ↗

April 29, 2025

Wall Street modestly up as investors await economic data and corporate earnings. Bond market continues rally, gold and oil prices fall.Wall Street rises modestly, bond market continues rally, gold and...

Via Benzinga

Topics Bonds

3 Value Stocks Facing Headwinds

April 29, 2025

Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few...

Via StockStory

Incyte (NASDAQ:INCY) Delivers Strong Q1 Numbers

April 29, 2025

Via StockStory

Incyte Reports 2025 First Quarter Financial Results and Provides Updates on Key Clinical Programs

April 29, 2025

From Incyte

Via Business Wire

Incyte (INCY) Q1 Earnings Report Preview: What To Look For

April 28, 2025

Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) will be reporting results tomorrow morning. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence Government World Trade

Incyte to Highlight Early-Stage Oncology Data at American Association for Cancer Research Annual Meeting 2025

April 25, 2025

From Incyte

Via Business Wire

Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

April 23, 2025

From Incyte

Via Business Wire

INCYTE CORP (NASDAQ:INCY) is probably undervalued for the fundamentals it is displaying. ↗

April 15, 2025

Take a closer look at INCYTE CORP , a remarkable value stock. NASDAQ:INCY excels in fundamentals and maintains a very reasonable valuation.

Via Chartmill

Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers

April 15, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Exact Sciences (NASDAQ:EXAS) and its peers.

Via StockStory

Topics Artificial Intelligence

Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)

April 14, 2025

Looking back on immuno-oncology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Regeneron (NASDAQ:REGN) and its peers.

Via StockStory

Topics Artificial Intelligence

Incyte to Report First Quarter Financial Results

April 10, 2025

From Incyte

Via Business Wire

What's going on in today's session: S&P500 movers ↗

April 09, 2025

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Wednesday.

Via Chartmill

These S&P500 stocks are gapping in today's session ↗

April 09, 2025

Stay updated with the S&P500 gap up and gap down stocks on Wednesday. Get a glimpse of the market's movement during today's session.

Via Chartmill

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

30 31 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.